Advertisement
Screener

EyePoint, Inc. (EYPT) Segment Reporting Other Item Amount

2.8 / 5 stars · 68/120 Roast Me

EyePoint, Inc. Segment Reporting Other Item Amount

EyePoint, Inc. (EYPT) reported Segment Reporting Other Item Amount of $4.39 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Notes › Segment Reporting

us-gaap:SegmentReportingOtherItemAmount · last filed 2026-08-05

  • EyePoint, Inc. segment reporting other item amount for the quarter ending 2026-06-30 was $4.39M, a 23.28% increase year-over-year.
  • EyePoint, Inc. segment reporting other item amount for the quarter ending 2026-03-31 was $4.96M, a 10.30% increase year-over-year.
  • EyePoint, Inc. segment reporting other item amount for the quarter ending 2025-12-31 was $4.17M, a 9.37% increase year-over-year.
  • EyePoint, Inc. segment reporting other item amount for the quarter ending 2025-09-30 was $4.01M, a 15.31% increase year-over-year.
  • EyePoint, Inc. segment reporting other item amount for fiscal 2025 was $16.24M, a 16.66% increase from fiscal 2024.
  • EyePoint, Inc. segment reporting other item amount for fiscal 2024 was $13.92M, a 23.39% decline from fiscal 2023.
  • EyePoint, Inc. segment reporting other item amount for fiscal 2023 was $18.18M.
Period endSegment Reporting Other Item Amount 3 monthSegment Reporting Other Item Amount 3 month as first filedSegment Reporting Other Item Amount 6 monthSegment Reporting Other Item Amount 9 monthSegment Reporting Other Item Amount 12 monthSegment Reporting Other Item Amount 12 month as first filed
2026-06-30$4.39M
10-Q · filed 2026-08-05
$9.40M
10-Q · filed 2026-08-05
$13.52M
derived: sum of 3 quarters · filed 2026-08-05
$17.54M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$4.96M
10-Q · filed 2026-05-07
$9.13M
derived: sum of 2 quarters · filed 2026-05-07
$13.14M
derived: sum of 3 quarters · filed 2026-05-07
$16.70M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$4.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$8.18M
derived: sum of 2 quarters · filed 2026-03-05
$11.74M
derived: sum of 3 quarters · filed 2026-08-05
$16.24M
10-K · filed 2026-03-05
2025-09-30$4.01M
10-Q · filed 2025-11-06
$7.58M
derived: sum of 2 quarters · filed 2026-08-05
$12.08M
10-Q · filed 2025-11-06
$15.88M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$3.56M
10-Q · filed 2026-08-05
$8.06M
10-Q · filed 2026-08-05
$11.87M
derived: sum of 3 quarters · filed 2026-08-05
$15.35M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$4.50M
10-Q · filed 2026-05-07
-$4.50M
10-Q · filed 2025-05-08
$8.31M
derived: sum of 2 quarters · filed 2026-05-07
$11.79M
derived: sum of 3 quarters · filed 2026-05-07
$15.38M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$3.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$7.29M
derived: sum of 2 quarters · filed 2026-03-05
$10.88M
derived: sum of 3 quarters · filed 2026-03-05
$13.92M
10-K · filed 2026-03-05
$13.94M
10-K · filed 2025-03-06
2024-09-30$3.48M
10-Q · filed 2025-11-06
$7.08M
derived: sum of 2 quarters · filed 2025-11-06
$10.12M
10-Q · filed 2025-11-06
2024-06-30$3.59M
10-Q · filed 2025-08-07
$6.63M
10-Q · filed 2025-08-07
2024-03-31-$3.04M
10-Q · filed 2025-05-08
2023-12-31$18.18M
10-K · filed 2025-03-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
908 Devices Inc. (MASS)United States$0.476B-9.53
Quanterix Corp (QTRX)United States$0.150B-1.65
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15